In cancer, the cognitive receptor for GDF-15 is unknown; however, the C-terminal fragment of ANGPTL4, used in this study, can bind and activate β1 and β5 integrins, which could aid invasion (Goh et al., 2010). Here, ANGPTL4 is linked to cancer.